Topic
Biotech
Startups, financing rounds, public offerings and the science behind them.
TrackerIPO window
Biotech IPOs are the sector's lifeblood. Here is how this year's class is performing.
Eleven drug developers have listed in the U.S. this year. Seven are trading above their offering price.
Updated Sept. 25, 2026Biotech
Deep DiveEmerging biotech
Biotech startups run on venture capital. Track this year's funding rounds.
Updated Sept. 14, 2026Biotech
The day in drug development, by 7 a.m.
One email each weekday with the stories our editors would send a colleague. Free, and you can leave whenever you like.